BioMedX Group, Inc.

BioMedX Group, Inc. is a deep tech startup that focuses on delivering innovative biomechanical simulations. The company has developed a proprietary 3D physics engine, X3, which is designed to provide highly-accurate biomechanical simulations. At the core of X3 is the novel mathematical approach, Direct Simplicial Dynamics (DSD), developed by their Chief Scientist.

X3 DSD and its novel mathematical approach have been discussed and published in a peer-reviewed journal, Engineering Reports, by Wiley. DSD sets itself apart from the traditional Finite Element Method (FEM) and offers advantages over other methods such as Ball-and-Spring for biomechanical simulations.

Currently, X3 Version 1.0 is being utilized in the FACIEM Aesthetics Simulator, developed by BioMedX, to simulate the post-procedural outcomes of popular medical aesthetic procedures. Moreover, the company has received an Epic Megagrant from Epic Games for the proposal to develop an X3 Plugin for Unreal Engine for gaming, Metaverse, and other non-medical applications development. Overall, BioMedX Group, Inc. presents a compelling value proposition with its advanced technology and varied applications in the medical and non-medical fields. The company's pioneering approach to biomechanical simulations and the utilization of the X3 engine in the FACIEM Aesthetics Simulator demonstrate its potential for disrupting the biomedical and gaming industries. Additionally, receiving support from well-established entities like Wiley and Epic Games signifies confidence in BioMedX's capabilities. With its foundation dating back to 2016 and its headquarters in the United States, BioMedX Group, Inc. appears to be a promising player in the deep tech space, meriting attention from potential investors and stakeholders.